Abrdn PLC Charles River Laboratories International, Inc. Transaction History

Abrdn PLC

$51.7 Billion
Q4 2024

A detailed history of Abrdn PLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Abrdn PLC holds 17,817 shares of CRL stock, worth $2.68 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

17,817

Previous 18,844 5.45%

Holding current value

$2.68 Million

Previous $3.71 Million 11.4%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 24, 2025	SELL	$178.58 - $220.69 $183,401 - $226,648	-1,027 Reduced 5.45%	17,817 $3.29 Million
Q3 2024 Oct 24, 2024	SELL	$187.96 - $245.29 $20 Million - $26 Million	-106,170 Reduced 84.93%	18,844 $3.71 Million
Q2 2024 Aug 09, 2024	BUY	$206.39 - $268.73 $2.69 Million - $3.5 Million	13,011 Added 11.62%	125,014 $25.8 Million
Q1 2024 May 08, 2024	SELL	$203.52 - $273.43 $2 Million - $2.68 Million	-9,804 Reduced 8.05%	112,003 $30.3 Million
Q4 2023 Jan 31, 2024	BUY	$164.52 - $238.84 $18 Million - $26.1 Million	109,275 Added 871.97%	121,807 $28.8 Million
Q3 2023 Nov 06, 2023	SELL	$194.44 - $217.61 $78,553 - $87,914	-404 Reduced 3.12%	12,532 $2.46 Million
Q2 2023 Jun 20, 2024	SELL	$183.71 - $210.25 $27,556 - $31,537	-150 Reduced 1.15%	12,936 $2.72 Million
Q2 2023 Aug 04, 2023	SELL	$183.71 - $210.25 $27,556 - $31,537	-150 Reduced 1.15%	12,936 $2.72 Million
Q1 2023 Jun 20, 2024	SELL	$191.89 - $259.92 $1,918 - $2,599	-10 Reduced 0.08%	13,086 $2.64 Million
Q1 2023 Apr 28, 2023	SELL	$191.89 - $259.92 $1,918 - $2,599	-10 Reduced 0.08%	13,086 $2.64 Million
Q4 2022 Jun 20, 2024	SELL	$197.11 - $250.07 $19.5 Million - $24.7 Million	-98,907 Reduced 88.31%	13,096 $2.85 Million
Q4 2022 Feb 09, 2023	BUY	$197.11 - $250.07 $192,773 - $244,568	978 Added 8.07%	13,096 $2.85 Million
Q3 2022 Nov 10, 2022	BUY	$182.44 - $250.54 $18,608 - $25,555	102 Added 0.85%	12,118 $2.39 Million
Q2 2022 Aug 05, 2022	SELL	$204.13 - $302.4 $86,755 - $128,519	-425 Reduced 3.42%	12,016 $2.6 Million
Q1 2022 May 04, 2022	SELL	$255.51 - $362.11 $599,937 - $850,234	-2,348 Reduced 15.88%	12,441 $3.59 Million
Q4 2021 Feb 08, 2022	SELL	$351.38 - $448.68 $309,214 - $394,838	-880 Reduced 5.62%	14,789 $5.57 Million
Q3 2021 Nov 15, 2021	BUY	$372.64 - $458.3 $947,996 - $1.17 Million	2,544 Added 19.38%	15,669 $6.59 Million
Q2 2021 Aug 10, 2021	BUY	$294.17 - $371.65 $3.86 Million - $4.88 Million	13,125 New	13,125 $4.86 Million

Others Institutions Holding CRL

# of Institutions

710

Shares Held

49.8M

Call Options Held

122K

Put Options Held

239K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $7.66B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Abrdn PLC, based on Form 13F filings with the SEC.

News

Stay updated on Abrdn PLC with notifications on news.

Account